Skip to main content
OpenTrials
Completed

NCT Number: NCT03699488

Messaging Therapy for Depression and Anxiety: A Longitudinal Effectiveness Study

Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Symptoms Anxiety Disorders Behavior Behavioral Symptoms Depression Mental Disorders

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed Depression and/or Anxiety Disorder

Exclusion criteria

  • Any psychosis related symptoms or disorders

Treatment and study plan

psychotherapy via asynchronous message

Behavioral

Behavioral psychotherapy delivered by asynchronous message using the Talkspace application

Primary outcomes

  1. Change from Baseline in Depressive symptoms on the Patient Health Questionnaire - 9

    Time frame: Up to 52 weeks

    Patient Health Questionnaire - 9 (PHQ-9) is a measure of depression symptoms. It has 9 items, with a minimum of 0 and a maximum of 27, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.

  2. Change from Baseline in Anxiety symptoms on the Generalized Anxiety Disorder - 7

    Time frame: Up to 52 weeks

    Generalized Anxiety Disorder - 7 (GAD-7) is a measure of anxiety symptoms. It has 7 items, with a minimum of 0 and a maximum of 21, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.

Secondary outcomes

  1. Mean number of words sent from patient to therapist

    Time frame: Up to 52 weeks

    Word counts of the words contained within messages sent

  2. Mean number of words sent from therapist to patient

    Time frame: Up to 52 weeks

    Word counts of the words contained within messages sent

Sponsors and collaborators

Lead sponsor

Talkspace

Industry

Collaborators

  • Columbia University
  • New York University

Registry information

Official study title

Asynchronous Messaging Therapy for Depression and Anxiety: A Longitudinal Study

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Oct 9, 2018
Registry last updated
Feb 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.